Detalhe da pesquisa
1.
An interdisciplinary consensus on the management of brain metastases in patients with renal cell carcinoma.
CA Cancer J Clin
; 72(5): 454-489, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35708940
2.
Cabozantinib plus Nivolumab and Ipilimumab in Renal-Cell Carcinoma.
N Engl J Med
; 388(19): 1767-1778, 2023 May 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37163623
3.
Comparison of outcomes for Hispanic and non-Hispanic patients with advanced renal cell carcinoma in the International Metastatic Renal Cell Carcinoma Database.
Cancer
; 130(11): 2003-2013, 2024 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38297953
4.
Impact of smoking status on clinical outcomes in patients with metastatic renal cell carcinoma treated with first-line immune checkpoint inhibitor-based regimens.
Oncologist
; 2024 Apr 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38630540
5.
Trends in health care spending on kidney cancer in the United States, 1996-2016.
Cancer
; 129(14): 2161-2168, 2023 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37005866
6.
Outcomes of relapsed clinical stage I versus de novo metastatic testicular cancer patients: an analysis of the IGCCCG Update database.
Br J Cancer
; 129(11): 1759-1765, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37777577
7.
Health-Related Quality of Life Outcomes With Two Different Starting Doses of Lenvatinib in Combination With Everolimus for Previously Treated Renal Cell Carcinoma.
Oncologist
; 28(1): 59-71, 2023 01 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35881028
8.
Development and Validation of a Prognostic Risk Model for Patients with Advanced Melanoma Treated with Immune Checkpoint Inhibitors.
Oncologist
; 28(9): 812-822, 2023 09 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37011230
9.
Characterization of Patients With Metastatic Renal Cell Carcinoma Experiencing Complete Response to First-line Therapies: Results From the International Metastatic Renal Cell Carcinoma Database Consortium.
J Urol
; 209(4): 701-709, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36573926
10.
Impact of the COVID-19 pandemic on cancer diagnoses, stage and survival in Alberta.
CMAJ
; 195(23): E804-E812, 2023 06 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37308211
11.
LITESPARK-011: belzutifan plus lenvatinib vs cabozantinib in advanced renal cell carcinoma after anti-PD-1/PD-L1 therapy.
Future Oncol
; 19(2): 113-121, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36752726
12.
A comparison of sunitinib with cabozantinib, crizotinib, and savolitinib for treatment of advanced papillary renal cell carcinoma: a randomised, open-label, phase 2 trial.
Lancet
; 397(10275): 695-703, 2021 02 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33592176
13.
Complementary Medicine Use Amongst Patients with Metastatic Cancer Enrolled in Phase III Clinical Trials.
Oncologist
; 27(3): e286-e293, 2022 03 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35274718
14.
A Randomized Phase II Study of AGS-16C3F Versus Axitinib in Previously Treated Patients with Metastatic Renal Cell Carcinoma.
Oncologist
; 26(3): 182-e361, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33289953
15.
Impact of Time to Surgery and Surgical Delay on Oncologic Outcomes for Renal Cell Carcinoma.
J Urol
; 205(1): 78-85, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-32614274
16.
The Effects of COVID-19 on Cancer Care Provision: A Systematic Review.
Cancer Control
; 28: 1073274821997425, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33631953
17.
Real-World Assessment of Clinical Outcomes Among First-Line Sunitinib Patients with Clear Cell Metastatic Renal Cell Carcinoma (mRCC) by the International mRCC Database Consortium Risk Group.
Oncologist
; 25(5): 422-430, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31971318
18.
Management of Germ Cell Tumors During the Outbreak of the Novel Coronavirus Disease-19 Pandemic: A Survey of International Expertise Centers.
Oncologist
; 25(10): e1509-e1515, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32735386
19.
Top 100 cited manuscripts in aortic valve replacement: A bibliometric analysis.
J Card Surg
; 35(11): 2943-2949, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32789989
20.
Cabozantinib in advanced non-clear-cell renal cell carcinoma: a multicentre, retrospective, cohort study.
Lancet Oncol
; 20(4): 581-590, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30827746